The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot ...

NSYNC entertainer diagnosed with rare form of diabetes that happens in adulthood but is more like Type 1 than Type 2.

World Obesity Day, observed on March 4th, emphasizes the dangers of the combined effects of diabetes and obesity, termed ...

Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...